EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer

Gregory Gaughran, Neha Aggarwal, Bruce Shadbolt, Robin Stuart-Harris

Breast Cancer Management · 2020-12 · 9 (4)

DOI: 10.2217/bmt-2020-0015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Management, online erschienen am 18.09.2020. Verfasst von Gregory Gaughran und 3 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer antigen 15.3 (CA15.3) is a commonly used tumor marker (TM) in metastatic breast cancer (MBC) but may not be raised. We assessed CA15.3, carcinoembryonic antigen (CEA), cancer antigen 125 (CA-125) and cancer antigen 19.9 in 193 MBC patients at diagnosis and follow-up. Materials & methods: This TM panel was measured approximately 3 monthly. Median follow-up was 29.3 months.

Results

At diagnosis, the following TMs were raised: CA15.3 63.2%, CEA 37.3%, CA-125 45.0% and cancer antigen 19.9 17.3%. CA15.3 became raised later in 28/71. Raised TMs were less common in HER2+ tumors. CA-125 was frequently raised in triple negative tumors and was associated with pleural metastases. More raised TMs correlated with more sites of metastases and shorter survival.

Conclusion

CEA and CA-125 showed benefit over CA15.3 alone in MBC and all three should be considered in MBC.

Zitieren

APA

Gaughran, G., Aggarwal, N., Shadbolt, B., & Stuart-Harris, R. (2020). The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer. Breast Cancer Management, 9(4). https://doi.org/10.2217/bmt-2020-0015

Vancouver

Gaughran G, Aggarwal N, Shadbolt B, Stuart-Harris R. The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer. Breast Cancer Management. 2020;9(4). doi:10.2217/bmt-2020-0015

BibTeX
@article{Gaughran2020,
  author = {Gaughran, Gregory and Aggarwal, Neha and Shadbolt, Bruce and Stuart-Harris, Robin},
  title = {The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer},
  journal = {Breast Cancer Management},
  year = {2020},
  volume = {9},
  number = {4},
  doi = {10.2217/bmt-2020-0015}
}
Kostenlos starten →